Double-Blind Placebo-Controlled Pilot Study of Acamprosate in Fragile X Syndrome

被引:0
|
作者
Erickson, Craig [1 ]
Pedapati, Ernest [1 ]
Shaffer, Rebecca [1 ]
Dominick, Kelli [1 ]
Schmitt, Lauren [1 ]
Wink, Logan [1 ]
Sweeney, John [1 ]
Berry-Kravis, Elizabeth [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
关键词
Fragile X Syndrome; Acamprosate; Clinical Trial;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
W23
引用
收藏
页码:289 / 290
页数:2
相关论文
共 50 条
  • [1] A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome
    Berry-Kravis, Elizabeth
    Horrigan, Joseph P.
    Tartaglia, Nicole
    Hagerman, Randi
    Kolevzon, Alexander
    Erickson, Craig A.
    Hatti, Shivkumar
    Snape, Mike
    Yaroshinsky, Alex
    Stoms, George
    Glass, Larry
    Jones, Nancy E.
    [J]. PEDIATRIC NEUROLOGY, 2020, 110 : 30 - 41
  • [2] A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence
    Kampman, Kyle M.
    Dackis, Charles
    Pettinati, Helen M.
    Lynch, Kevin G.
    Sparkman, Thorne
    O'Brien, Charles P.
    [J]. ADDICTIVE BEHAVIORS, 2011, 36 (03) : 217 - 221
  • [3] A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
    Andrew Ligsay
    Anke Van Dijck
    Danh V. Nguyen
    Reymundo Lozano
    Yanjun Chen
    Erika S. Bickel
    David Hessl
    Andrea Schneider
    Kathleen Angkustsiri
    Flora Tassone
    Berten Ceulemans
    R. Frank Kooy
    Randi J. Hagerman
    [J]. Journal of Neurodevelopmental Disorders, 2017, 9
  • [4] Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
    Berry-Kravis, Elizabeth
    Portes, Vincent Des
    Hagerman, Randi
    Jacquemont, Sebastien
    Charles, Perrine
    Visootsak, Jeannie
    Brinkman, Marc
    Rerat, Karin
    Koumaras, Barbara
    Zhu, Liansheng
    Barth, Gottfried Maria
    Jaecklin, Thomas
    Apostol, George
    von Raison, Florian
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (321)
  • [5] A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
    Ligsay, Andrew
    Van Dijck, Anke
    Nguyen, Danh V.
    Lozano, Reymundo
    Chen, Yanjun
    Bickel, Erika S.
    Hessl, David
    Schneider, Andrea
    Angkustsiri, Kathleen
    Tassone, Flora
    Ceulemans, Berten
    Kooy, R. Frank
    Hagerman, Randi J.
    [J]. JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2017, 9
  • [6] A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
    Leigh, Mary Jacena S.
    Nguyen, Danh V.
    Mu, Yi
    Winarni, Tri I.
    Schneider, Andrea
    Chechi, Tasleem
    Polussa, Jonathan
    Doucet, Paul
    Tassone, Flora
    Rivera, Susan M.
    Hessl, David
    Hagerman, Randi J.
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2013, 34 (03): : 147 - 155
  • [7] Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome
    Torrioli, MG
    Vernacotola, S
    Mariotti, P
    Bianchi, E
    Calvani, M
    De Gaetano, A
    Chiurazzi, P
    Neri, G
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 87 (04): : 366 - 368
  • [8] DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY OF FOLINIC ACID (LEUCOVORIN(R)) FOR THE TREATMENT OF FRAGILE-X SYNDROME
    STROM, CM
    BRUSCA, RM
    PIZZI, WJ
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 44 (05): : 676 - 682
  • [9] A double-blind, placebo-controlled, pilot study of mirtazapine in essential tremor
    Lyons, KE
    Pahwa, R
    [J]. NEUROLOGY, 2002, 58 (07) : A254 - A254
  • [10] Double-blind placebo-controlled pilot study of paroxetine for specific phobia
    J. Benjamin
    I. Z. Ben-Zion
    E. Karbofsky
    P. Dannon
    [J]. Psychopharmacology, 2000, 149 : 194 - 196